On the other hand, although Rapamycin suppressed AP-1 activation in 786-0 and UOK121 cells, it failed to significantly inhibit phosphorylation of TAK1 and c-Jun in RCC cell lines, except for a temporary down-regulation of p-TAK1 and p-c-Jun expression. This evidence concerns the gene FOS and renal cell carcinoma.